(Reuters) - Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking the company's plan to change the way it offers drug discounts to ...

Amid ongoing controversy over 340B drug discounts, a sweeping review suggests the program is doing what it was intended to do: generate revenue for hospitals, clinics and pharmacies by requiring ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "MFN reinforces the worst incentives in 340B, shifts costs ...

Drugmakers have to continue paying hospitals upfront discounts for drugs in the 340B program — at least in the near term — after a federal court ruled late last week against major manufacturers that ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

Your recent story, 340B Pricing Program: Serving Vulnerable Patients or Enriching Hospitals?, contains several factual errors and contextual inaccuracies and leaves unchallenged specious statements by ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...

The 340B Drug Pricing Program enacted in 1992 requires pharmaceutical manufacturers participating in the Medicaid program to provide statutorily defined discounts on "covered outpatient drugs" ...

COLUMBUS, Ohio -- The biggest and most important federal program you’ve likely never heard of has an obscure name – the 340B Drug Discount Program. It’s huge, growing rapidly, and deeply flawed in its ...

KINGSTON, N.Y.--(BUSINESS WIRE)--340Best, a 340B Program partner offering third-party administration and audit and consulting services, today announced its new Referrals+™ Program to provide an ...